To define the sites in the extracellular domain of the human thyrotropin (TSH) receptor that are involved in TSH binding and signal transduction we constructed chimeric thyrotropin-luteinizing hormone/chorionic gonadotropin (TSH-LH/CG) receptors. The extracellular domain of the human TSH receptor was divided into five regions that were replaced, either singly or in various combinations, with homologous regions of the rat LH/CG receptor. The chimeric receptors were stably expressed in Chinese hamster ovary cells.
The data obtained suggest that the carboxyl region of the extracellular domain (amino acid residues 261418) and particularly the middle region (residues 171-260) play a role in signal transduction. The possibility is also raised of an interaction between the amino and carboxyl regions of the extracellular domain in the process of signal transduction. With respect to hormone binding, substitution of the entire extracellular domain of the LH/CG receptor for the corresponding region of the TSH receptor resulted in high-affinity human CG binding with complete loss of TSH binding. Surprisingly, however, there was at least one chimera with a substitution at each of the five domains that still retained high-affinity TSH binding. Substitution of residues 1-170 of the TSH receptor with the corresponding region of the LH/CG receptor was associated with the retention of high-affinity TSH binding but ligand specificity was lost in that TSH and human CG could interact functionally with the receptor. In summary, these studies suggest that the middle region and carboxyl half of the extracellular domain of the TSH receptor are involved in signal transduction and that the TSH-binding region is likely to span the entire extracellular domain, with multiple discontinuous contact sites.
The human thyrotropin (TSH) receptor (1) (2) (3) (4) (5) (6) belong to a subgroup of the guanine nucleotide (G) regulatory protein-coupled receptor family with very large extracellular domains. With 14 incomplete leucine-rich repeated segments this subgroup's receptors are also members of the leucine-rich glycoprotein family (7) (8) (9) (10) (11) 
902
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
phage DNA extracted from a rat ovarian library (Clontech) and two oligonucleotides containing the appropriate restriction sites at their 5' ends. These restriction sites were then used for substitution of the LH/CG receptor cDNA fragments into TSH receptor cDNA from which the corresponding region had been deleted using the same restriction enzymes. The nucleotide sequences of the PCR-generated fragments of the rat LH/CG receptor as well as the ligation sites and adjacent nucleotide sequences of the TSH receptor in the chimeric constructs were determined (20) in full and compared to the previously published sequence data (1, 4) . Only chimeric cDNAs without any amino acid substitutions were chosen. The chimeric TSH-LH/CG cDNA was transfected into Chinese hamster ovary (CHO) cells by the calcium-phosphate method (21) . Surviving colonies were selected by G418
(400 1g/ml) and pooled for study of their ability to bind to TSH and hCG and to respond to TSH and hCG with respect to an increase in intracellular cAMP levels.
TSH and hCG Binding and Intracellular cAMP Measurements. TSH-binding studies were performed as described (22) with the exception that highly purified bovine TSH (30 units/mg of protein) was iodinated with 125I to =80 ,uCi/,ug of protein using the Bolton-Hunter reagent (4400 Ci/mmol; 1 Ci = 37 GBq; New England Nuclear). In addition, we tested competition for 1251-labeled TSH (125I-TSH) binding with hCG as well as TSH (Sigma). Nonspecific 125I-TSH binding was determined in the presence of 1 ,uM TSH and this value was subtracted from total binding to yield specific TSH binding. hCG binding was determined as for TSH with the exceptions that we used the conditions of Buettner and Ascoli (23) . As ligand we used highly purified hCG (11, 000 units/mg of protein) radiolabeled with 1251 by the stoichiometric chloramine-T method (24) to a specific activity of 50 ,uCi/,g of protein.
Measurements of the intracellular cAMP response to hormone stimulation (1 hr at 37°C) were as described (25) .
RESULTS
To conserve the three-dimensional structure of the TSH receptor we constructed 11 chimeric human TSH-rat LH/CG receptor cDNAs (Fig. 1 ), which were then stably expressed in CHO cells. For chimeric receptor construction we divided the extracellular domain of the human TSH receptor into five regions by restriction endonuclease sites, three of which sites were introduced by site-directed mutagenesis. One or more of these regions were replaced with the homologous region of the rat LH/CG receptor. Pools of stably transfected clones of cells were tested for their ability to bind to TSH and hCG and to respond to TSH and hCG stimulation in terms of an increase in intracellular cAMP levels.
The human TSH receptor with two conserved amino acid substitutions (introduced with the three new restriction sites (4, 23) as well as a cAMP response to hCG stimulation ( Fig. 1 and Table 1 ). This chimera did not demonstrate high-affinity TSH binding. These data indicate that, as anticipated, the extracellular domains of the glycoprotein hormone receptors are critical for their respective ligand binding. Of the chimeric receptors in which only a single TSH receptor region was replaced (chimeras TSH-LHR-1 through TSH-LHR-5), chimeras TSH-LHR-1 (substitution of TSH receptor residues 1-82) and TSH-LHR-3 (residues 171-260) lost their high-affinity TSH-binding site. In contrast, chimeras TSH-LHR-2 (residues 83-170), TSH-LHR-4 (residues 261-360), and TSH-LHR-5 (residues 361-418) bound TSH with high affinity. As with the wild-type TSH receptor (22) , hCG did not bind to chimeras TSH-LHR-2, TSH-LHR-4, and TSH-LHR-5, indicating that these chimeras retained their specificity for TSH binding. Functionally, as determined by the intracellular cAMP response to TSH stimulation (Table 1) chimeras TSH-LHR-1 and TSH-LHR-3 were totally inactive, as expected in view of their inability to bind the hormone with high affinity. In contrast, chimeras TSH-LHR-4 and TSH-LHR-5, with high affinities for TSH binding, had blunted cAMP responses to TSH stimulation. TSH-LHR-2 had normal high-affinity TSH binding and a normal cAMP response to TSH stimulation. None of these chimeras responded to hCG stimulation.
The foregoing data suggested that the carboxyl-terminal region of the TSH receptor extracellular domain played a role in signal transduction and that amino acid residues in two discontinuous regions (1-82 and 171-260) in the TSH receptor extracellular region were important for TSH binding. Surprisingly, however, more extensive substitutions of these regions in chimeras TSH-LHR-8 (residues 1-170) and TSH-LHR-9 (residues 1-260, representing 62% ofthe extracellular domain) were associated with high-affinity TSH binding (Table 1) . Furthermore, these chimeras also lost their complete specificity for TSH and also interacted with hCG, though with a lower affinity than for chimera TSH-LHR-11 containing the entire LH/CG extracellular domain. Remarkably, despite their similar, high-affinity TSH binding, there was a dichotomy in the functional activity of these two chimeras. Thus, the cellular cAMP response to TSH stimulation with TSH-LHR-8 was similar to that of the wild-type TSH receptor (Table 1) . Consistent with the binding data, hCG also increased intracellular cAMP levels in TSH-LHR-8. In contrast, chimera TSH-LHR-9 was functionally unresponsive to TSH and hCG stimulation. This complete dissociation between ligand binding and receptor function in TSH-LHR-8 and TSH-LHR-9 implicates domain C (residues 171-260) (Fig. 1) in the transduction of a signal by the TSH receptor.
Focusing on the carboxyl terminus of the TSH receptor extracellular domain, with chimera TSH-LHR-6 (residues 261-418), a more extensive substitution than TSH-LHR-5 (see above), TSH still bound with high affinity similar to the wild-type receptor (Table 1) . However, in contrast to their normal TSH binding, the signal transduction of these mutant receptors was impaired but not abolished. Further substitution of the carboxyl region of the TSH receptor extracellular domain (TSH-LHR-7; residues 171-418) abolished highaffinity TSH binding.
Substitutions ofamino-terminal and carboxyl-terminal segments ofthe TSH receptor in chimera TSH-LHR-10 (residues 1-170 and 361-418) did not alter high-affinity TSH binding (Table 1) in accordance with their individual substitutions (TSH-LHR-8 and TSH-LHR-5). Chimera TSH-LHR-10 bound hCG with a relatively low affinity similar to TSH-LHR-8. Surprisingly, however, the sensitivity of the cAMP response to TSH stimulation of TSH-LHR-10 was increased 5-fold relative to the wild-type TSH receptor and contrasted with the reduced signal transduction with the isolated E domain substitution in chimera TSH-LHR-5.
In the chimeras that bound TSH and hCG (chimeras TSH-LHR-8, TSH-LHR-9, and TSH-LHR-10), to evaluate whether hCG was interacting with the chimeric receptors in the same region as TSH we also tested competition by hCG for 125I-TSH binding. In all three chimeras, hCG competed for 125I-TSH binding but only with low affinity (data not shown).
DISCUSSION
It is well-established that the intracellular, cytoplasmic domains of other members of the G protein-coupled receptor family play an important role in signal transduction (26, 27) . The majority of these receptors (which we term subgroup A) interact with very small ligands and lack significant extracellular domains. The present data with the TSH receptor, a member of this receptor family with substantial extracellular domains for large ligands (subgroup B), suggest that the middle region and carboxyl half of the extracellular domain of the TSH receptor (domains C, D, and E) (Fig. 1) play an important role in signal transduction. Domain C appears to be particularly dominant. This mechanism would differ from the A subgroup of receptors (such as the adrenergic receptors), in which the ligand interacts directly with transmembrane regions. The data with chimera TSH-LHR-10 also raise the possibility of an interaction between discontinuous aminoand carboxyl-terminal regions of the receptor extracellular domain (domains A, B, and E) in the process of signal transduction. It is also interesting that the amino and carboxyl regions of the extracellular domain ofthe TSH receptor are rich in cysteine residues that are conserved among members of receptor subgroup B (1, (4) (5) (6) 28) , and there is evidence for the existence of disulfide-linked subunits in the TSH receptor (12 (13, 14) , homologous substitutions in a limited number of sites in the TSH receptor are tolerated without significant change in high-affinity ligand binding.
The present data provide information not only about the TSH receptor but also about the LH/CG receptor. Unlike with the TSH receptor, none of the chimeras studied retained high-affinity hCG binding, even though some did interact with this hormone with relatively low affinity. Therefore, the LH/CG receptor appears to be less tolerant of homologous substitution than the TSH receptor.
The chimeric receptor approach used in this study is a powerful means to define domains important for the unique functions of members of a homologous protein family. However, it does not identify regions that may be involved in a function common to all members of the protein family. For example, the glycoprotein hormones have a common a subunit that binds to the extracellular domain ofthe receptor. This common region would not be identified by the homologous substitution approach used. Indeed, mutagenesis studies of an 8-amino acid region (amino acid residues 38-45) in the human TSH receptor suggest that this region is critical for TSH binding (29) . Because homologous substitution of this region did not abolish high-affinity TSH binding (present study), it is likely to be a site of interaction with the common a subunit of the glycoprotein hormones.
In conclusion, the present data provide delineation of functional domains in the extracellular component of a member of the newly defined group of G protein-coupled receptors with large extracellular domains (subgroup B). The large extracellular domain of the TSH receptor makes this information a practical prerequisite for future detailed mutagenesis studies to define more precisely the amino acid residues involved in hormone binding and signal transduction.
